AKO-A vs LRN

The Advanced Deterministic Scorecard reveals severe financial health concerns with a Piotroski F-Score of just 0/9, indicating critical weakness in fundamental performance. Despite a strong ROE of 24.73% and a high dividend yield of 5.03%, the company's operating margin is 0.00%, debt/equity is elevated at 1.01, and technical trend is deeply bearish at 10/100. Revenue and earnings growth are solid year-over-year, but recent quarterly earnings surprises have been inconsistent, and the most recent Q/Q EPS growth is negative at -10.7%. The stock trades above the Graham Number of $224.66, but this appears to be a data error given the current price of $24.50, suggesting potential unit mismatch or data corruption.

LRN exhibits a stable financial profile with a Piotroski F-Score of 6/9 and exceptional liquidity, evidenced by a current ratio of 7.27. While the current price of $95.16 trades at a slight premium to the Graham Number ($72.77) and Intrinsic Value ($86.9), the valuation remains highly attractive with a PEG ratio of 0.51 and a forward P/E of 10.81. Strong profitability metrics, including an ROE of 22.26%, combined with a consistent track record of earnings beats, outweigh the current bearish technical trend. The company is fundamentally undervalued relative to its growth and efficiency.